from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0477/-

LFCtreatmentdescriptionclass of inhibitor

0.643

Amikacinug/mL Amikacintranslation

0.595

Cap5-10ug/mL Capreomycintranslation

3.246

Rox10-50 ug/mL Roxithromycintranslation

1.000

SM2-5 ug/mL Streptomycintranslation

1.621

Tet5-10 ug/mL Tetracyclinetranslation

-0.271

Rif0.2-5ug/mL Rifampicintranscription

-0.281

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.084

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.164

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.103

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.276

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.713

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.881

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.239

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.217

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.381

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.567

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.419

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.187

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.549

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.537

Nigericin50 uM Nigericinrespiration

0.043

TRC10-150 ug/mL Triclosanrespiration

0.115

TRZ10-25 ug/mL Thioridazinerespiration

3.047

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.067

menadione6-10 ug/mL Menadionerespiration

0.169

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.255

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.117

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.345

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.169

NRP_1Non-replicating persistence stage 1dosRassociated

-0.609

Amp0.2mg/mL AmpicillincellWall

-0.245

Cephalexin20-100 ug/mL CephalexincellWall

-0.343

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.083

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.842

EMB10-20 ug/mL EthambutolcellWall

-0.574

Eta12-40 ug/mL EthionamidecellWall

-0.274

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.327

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.805

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.641

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.864

BZA0.12 mg/mL BenzamidearomaticAmides

0.093

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.138

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.922

H2O24 mM hydrogen peroxideDNAdamaging

-0.248

Levo10 ug/mL LevofloxacinDNAdamaging

-0.292

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.230

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.417

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.545

UVUV-irradiationDNAdamaging

-0.683

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.324

Antimycin12.5-50 ug/mL Antimycin A?

-0.711

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.455

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.285

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.556

PA8240.2-2 ug/mL PA-824?

0.705

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.220

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.134

Verapamil50 uM Verapamil?

-0.423

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.475

methoxatin10-20 ug/mL Methoxatin?